Guardant Health Inc GH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:23 AM EDT
158.00quote price arrow down-1.20 (-0.75%)
Volume
126,657
52 week range
66.84 - 181.07

...

Loading . . .
  • Open159.27
  • Day High159.66
  • Day Low156.58
  • Prev Close159.20
  • 52 Week High181.07
  • 52 Week High Date02/12/21
  • 52 Week Low66.84
  • 52 Week Low Date04/15/20

Key Stats

  • Market Cap15.868B
  • Shares Out100.43M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta0.5
  • YTD % Change23.21

KEY STATS

  • Open159.27
  • Day High159.66
  • Day Low156.58
  • Prev Close159.20
  • 52 Week High181.07
  • 52 Week High Date02/12/21
  • 52 Week Low66.84
  • 52 Week Low Date04/15/20
  • Market Cap15.868B
  • Shares Out100.43M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta0.5
  • YTD % Change23.21

RATIOS/PROFITABILITY

  • EPS (TTM)-2.58
  • P/E (TTM)-61.24
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-227.449M
  • ROE (MRQ)-24.21%
  • Revenue (MRQ)286.73M
  • Gross Margin (MRQ)67.73%
  • Net Margin (MRQ)-85.89%
  • Debt To Equity (MRQ)62.09%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Guardant Health Inc

There is no recent news for this security.

Profile

MORE
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures...
AmirAli Talasaz Ph.D.
Chairman
Helmy Eltoukhy Ph.D.
Chief Executive Officer
Michael Bell
Chief Financial Officer
Kumud Kalia
Chief Information Officer
Address
505 Penobscot Dr
Redwood City, CA
94063-4737
United States

Top Peers

SYMBOLLASTCHG%CHG
ALNY
Alnylam Pharmaceuticals Inc
138.86-0.16-0.12%
NVAX
Novavax Inc
205.93+3.84+1.90%
NTRA
Natera Inc
104.81-1.54-1.45%
NVTA
Invitae Corp
38.16-0.90-2.30%
RARE
Ultragenyx Pharmaceutical Inc
108.12-1.45-1.33%